Irhythm Technologies Inc.(IRTC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IRTC Irhythm Technologies Inc.

交易中 10-07 14:58:44 EDT

106.42

-0.78

-0.73%

最高108.01	最低104.70	成交量23.39万
今开105.97	昨收107.20	日振幅3.09%
总市值34.96亿	流通市值33.69亿	总股本3,285万
成交额2,484万	换手率0.74%	流通股本3,165万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IRTC","market":"US","secType":"STK","nameCN":"Irhythm Technologies Inc.","latestPrice":106.42,"timestamp":1791399522649,"preClose":107.2,"halted":0,"volume":233923,"delay":0,"changeRate":-0.007276119402985085,"floatShares":31654499,"shares":32853800,"eps":-0.429673,"marketStatus":"交易中","change":-0.78,"latestTime":"10-07 14:58:44 EDT","open":105.97,"high":108.01,"low":104.7,"amount":24835516.01926,"amplitude":0.030877,"askPrice":106.51,"askSize":116,"bidPrice":106.31,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-0.429673,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791403200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1476936000000,"exchange":"NASDAQ","adjPreClose":107.2,"preHourTrading":{"tag":"盘前","latestPrice":107.44,"preClose":107.2,"latestTime":"09:26 EDT","volume":673,"amount":72870.647128,"timestamp":1791379572204,"change":0.24,"changeRate":0.002239,"amplitude":0.026026},"postHourTrading":{"tag":"盘后","latestPrice":108,"preClose":107.2,"latestTime":"19:30 EDT","volume":17413,"amount":1866737.883,"timestamp":1791329402733,"change":0.8,"changeRate":0.007463,"amplitude":0.007463},"volumeRatio":0.657617,"impliedVol":0.5352,"impliedVolPercentile":0.5737},"requestUrl":"/m/hq/s/IRTC/wiki","defaultTab":"wiki","newsList":[{"id":"1173148454","title":"iRhythm与Baxter互授心脏监测传感器专利免版税许可——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1173148454","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173148454?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:19","pubTimestamp":1786047553,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，iRhythm Technologies Inc.与Baxter公司已达成协议，相互授予对方心脏监测传感器专利的免版税许可。这一举措，意味着两家企业能够在无需支付专利使用费的前提下，自由使用对方在心脏监测传感器领域的相关专利技术。通过这种互惠互利的安排，双方均有望加速各自产品的研发进程，并进一步巩固其在心脏监测技术市场的竞争地位。该协议的签署，无疑是两家公司在医疗科技领域合作的一次重要深化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IRTC","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171563474","title":"Irhythm Technologies 控股交易：预计2027年起提升营收增速，并维持15%调整后息税折旧摊销前利润率目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1171563474","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171563474?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:08","pubTimestamp":1786046890,"startTime":"0","endTime":"0","summary":"Irhythm Technologies 控股公司达成一项交易，市场普遍预期此举将从2027年开始显著提振其营收增长率。与此同时，公司管理层重申，2027年经调整后的息税折旧摊销前利润率（Adj Ebitda Margin）目标仍将维持在15%的水平。这一战略布局，旨在强化公司未来的财务表现，为长期增长注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4082","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113550132","title":"iRhythm拟收购Vitalconnect，推动心脏监测平台覆盖门诊、住院及院后居家全场景","url":"https://stock-news.laohu8.com/highlight/detail?id=1113550132","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113550132?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:07","pubTimestamp":1786046830,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc.（简称Irhythm）宣布，将收购Vitalconnect。此举旨在将其心脏监测平台从门诊拓展至住院以及院后居家护理领域，实现全方位覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4082","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178864937","title":"财报前瞻｜Irhythm Technologies Inc.本季度营收预计增长26.09%，机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1178864937","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178864937?lang=zh_cn&edition=full","pubTime":"2026-07-31 00:33","pubTimestamp":1785429237,"startTime":"0","endTime":"0","summary":"Irhythm Technologies Inc.将于2026年08月06日发布财报，市场预期本季度营收与利润率改善延续，关注支付端与医疗机构渠道动能。市场一致预期Irhythm Technologies Inc.本季度营收为2.19亿美元，同比增长26.09%；预计调整后每股收益为-0.00美元，同比改善99.08%；预计EBIT为-0.28百万美元，同比改善81.35%。基于近期六个月内对Irhythm Technologies Inc.的外部研究与观点梳理，市场看多观点占据主导。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Irhythm Technologies Inc.本季度营收预计增长26.09%，机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113342515","title":"iRhythm披露：通过第三方应用社会工程攻击获取受影响数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1113342515","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113342515?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:36","pubTimestamp":1781555792,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc. 在提交给美国证券交易委员会（SEC）的文件中披露，有受影响的数据是通过针对第三方应用程序的社会工程手段获取的。这一事件凸显了在数字医疗数据管理过程中，供应链及合作伙伴环节存在的潜在安全风险。公司目前正在评估此事件的影响范围，并已启动相应的应对与通知程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4082","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143797693","title":"iRhythm 向SEC提交文件：确认产品、临床系统、患者安全及运营未受影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1143797693","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143797693?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:35","pubTimestamp":1781555758,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc. 在向美国证券交易委员会（SEC）提交的文件中明确表示，近期公司运营未发现对旗下产品、临床系统、患者安全或整体业务运作产生任何影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4082","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109136285","title":"iRhythm披露：6月9日收到威胁者通讯，声称已获取敏感及患者数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1109136285","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109136285?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:33","pubTimestamp":1781555615,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，医疗技术公司Irhythm Technologies Inc.于6月9日收到了来自威胁行为方的通讯。对方声称已获取了公司的敏感信息及患者数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IRTC","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162437211","title":"iRhythm披露第三方托管业务应用遭未授权访问事件 - 美国证券交易委员会文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1162437211","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162437211?lang=zh_cn&edition=full","pubTime":"2026-06-16 04:32","pubTimestamp":1781555535,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc. (IRTC) 于近期向美国证券交易委员会提交文件，披露公司于2026年6月8日发现其部分由第三方托管的业务应用程序存在未授权访问活动。该公司已立即启动内部调查程序，并着手评估此次事件对业务运营及财务状况的潜在影响。目前，相关调查仍在进行中，公司表示将根据监管要求及时披露进一步信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4563","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168111229","title":"iRhythm达成具有约束力的和解协议，以解决集体诉讼证券诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=1168111229","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168111229?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:00","pubTimestamp":1780660814,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）提交的文件，iRhythm Technologies Inc. 已达成一项具有约束力的和解协议，旨在了结针对其提起的集体诉讼证券诉讼。\n该和解协议规定，iRhythm将支付4500万美元，以换取相关诉讼的驳回和索赔的解除。公司表示，预计此项和解协议不会对其调整后的息税折旧摊销前利润（EBITDA）、净利润或运营费用产生实质性影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IRTC","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153137298","title":"iRhythm达成和解协议 预计不影响调整后EBITDA、净利润及运营开支","url":"https://stock-news.laohu8.com/highlight/detail?id=1153137298","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153137298?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:49","pubTimestamp":1780660156,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc.向美国证券交易委员会（SEC）提交的文件显示，该公司近期达成的和解协议预计不会对其调整后税息折旧及摊销前利润（EBITDA）、净利润或运营开支产生实质性影响。\n该份监管文件明确阐述了和解协议相关的财务处理方式。公司管理层认为，此项协议的相关条款与成本已被充分评估，其影响已纳入现有财务框架。因此，核心盈利指标与日常运营成本结构预计将保持稳定。\n此消息向市场传递了明确的财务信号，即该和解事件属于一次性事项，不会干扰公司持续的经营业绩与既定的财务表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4082","IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168091056","title":"iRhythm达成和解协议，支付4500万美元以了结相关索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=1168091056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168091056?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:49","pubTimestamp":1780660155,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，医疗设备公司iRhythm Technologies Inc.已达成一项和解协议。该协议规定，公司将支付4500万美元，以换取相关索赔的撤销与豁免。此举旨在解决一桩悬而未决的法律纠纷，为公司未来的运营扫清潜在障碍。支付这笔款项意味着双方就争议事项达成了最终和解，相关法律程序将随之终止。此举可能有助于公司管理层将更多精力专注于核心业务的发展与创新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC","BK4563","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115662241","title":"iRhythm达成具约束力和解协议，以解决集体诉讼证券纠纷 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1115662241","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115662241?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:49","pubTimestamp":1780660154,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc. (IRTC) 已签订一项具有法律约束力的和解协议，旨在了结针对该公司提起的集体诉讼证券纠纷。根据提交给美国证券交易委员会(SEC)的文件，此举标志着相关法律程序进入关键阶段。该协议的达成有望消除持续诉讼带来的不确定性，为公司未来运营扫清潜在障碍。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4563","IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191659533","title":"财报前瞻｜Irhythm Technologies Inc.本季度营收预计增26.50%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1191659533","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191659533?lang=zh_cn&edition=full","pubTime":"2026-04-23 14:10","pubTimestamp":1776924654,"startTime":"0","endTime":"0","summary":"Irhythm Technologies Inc.将于2026年04月30日发布最新财报，市场聚焦营收与盈利拐点及核心客户结构变化。上季度Irhythm Technologies Inc.营收2.09亿美元，同比增长27.12%；毛利率70.88%；归属于母公司股东的净利润为557.90万美元，净利率2.67%，环比增长率为207.04%；调整后每股收益为0.29元，同比增长28.00%。近期覆盖Irhythm Technologies Inc.的机构观点呈偏乐观一侧占比更高，多数机构强调高增速收入与毛利结构支撑盈利修复路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Irhythm Technologies Inc.本季度营收预计增26.50%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227441","title":"Irhythm Technologies, Inc.跌2.51% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227441?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613495,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Irhythm Technologies, Inc.股票出现波动，股价急速下跌2.51%。Irhythm Technologies, Inc.股票所在的医疗器械行业中，整体跌幅为0.53%。Irhythm Technologies, Inc.公司简介：iRhythm Technologies Inc是一家商业阶段的数字医疗保健公司，通过将可穿戴生物传感技术与基于云的数据分析和机器学习功能相结合，重新定义了心脏心律失常的临床诊断方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213135a26a247c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213135a26a247c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4082","IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517909821","title":"Irhythm Technologies, Inc.盘中异动 急速跳水5.27%报102.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517909821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517909821?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:22","pubTimestamp":1741292567,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时22分，Irhythm Technologies, Inc.股票出现异动，股价快速跳水5.27%。Irhythm Technologies, Inc.股票所在的医疗器械行业中，整体跌幅为2.17%。Irhythm Technologies, Inc.公司简介：iRhythm Technologies Inc是一家商业阶段的数字医疗保健公司，通过将可穿戴生物传感技术与基于云的数据分析和机器学习功能相结合，重新定义了心脏心律失常的临床诊断方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307042247abebcc30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307042247abebcc30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4563","IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514165980","title":"Irhythm Technologies, Inc.盘中异动 早盘大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514165980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514165980?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:19","pubTimestamp":1740496799,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时19分，Irhythm Technologies, Inc.股票出现波动，股价大幅下挫5.02%。Irhythm Technologies, Inc.股票所在的医疗器械行业中，整体跌幅为0.30%。Irhythm Technologies, Inc.公司简介：iRhythm Technologies Inc是一家商业阶段的数字医疗保健公司，通过将可穿戴生物传感技术与基于云的数据分析和机器学习功能相结合，重新定义了心脏心律失常的临床诊断方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252319599892578d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252319599892578d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4563","IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756155","title":"Irhythm Technologies, Inc.2024财年实现净利润-1.13亿美元，同比增加8.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756155?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326485,"startTime":"0","endTime":"0","summary":"2月24日，Irhythm Technologies, Inc.公布财报，公告显示公司2024财年净利润为-1.13亿美元，同比增加8.13%；其中营业收入为5.92亿美元，同比增加20.08%，每股基本收益为-3.63美元。从资产负债表来看，Irhythm Technologies, Inc.总负债8.41亿美元，其中短期债务15.87百万美元，资产负债比为1.11，流动比率为5.82。机构评级：截至2025年2月24日，当前有12家机构对Irhythm Technologies, Inc.目标价做出预测，其中目标均价为133.00美元，其中最低目标价为104.00美元，最高目标价为152.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000217abd9c809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000217abd9c809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181219937","title":"异动解读 | IRTC盘中大涨6.33%,分析师上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1181219937","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181219937?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:38","pubTimestamp":1740148697,"startTime":"0","endTime":"0","summary":"iRhythm Technologies Inc.(IRTC)今日盘中大涨6.33%,引发投资者广泛关注。\n\n消息面上,分析师BTIG将该公司目标价从120美元上调至135美元。这表明分析师对IRTC公司未来发展前景持更加乐观态度,可能是引发该股今日大涨的主要原因。\n\n分析师目标价上调往往会促使投资者加大买入力度,从而推动股价上涨。不过具体原因仍有待进一步观察和分析,投资者也应当密切关注后续发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | IRTC盘中大涨6.33%,分析师上调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IRTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296521","title":"Irhythm Technologies, Inc.盘中异动 早盘快速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296521?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:32","pubTimestamp":1740148325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时32分，Irhythm Technologies, Inc.股票出现异动，股价快速上涨5.60%。Irhythm Technologies, Inc.股票所在的医疗器械行业中，整体跌幅为0.36%。Irhythm Technologies, Inc.公司简介：iRhythm Technologies Inc是一家商业阶段的数字医疗保健公司，通过将可穿戴生物传感技术与基于云的数据分析和机器学习功能相结合，重新定义了心脏心律失常的临床诊断方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223205abd7afa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223205abd7afa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRTC","BK4563","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149202120","title":"iRhythm Technologies第四季度销售额为1.643亿美元，超过预期的1.5794亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149202120","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149202120?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:09","pubTimestamp":1740085764,"startTime":"0","endTime":"0","summary":"iRhythm Technologies 报告的季度销售额为1.643亿美元，超过了分析师普遍预期的1.5794亿美元，超出4.02%。相比去年同期的1.3251亿美元，这一数字增加了23.99%。以上内容来自Benzinga Earnings专栏，原文如下：iRhythm Technologies  reported quarterly sales of $164.30 million which beat the analyst consensus estimate of $157.94 million by 4.02 percent.  This is a 23.99 percent increase over sales of $132.51 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"iRhythm Technologies第四季度销售额为1.643亿美元，超过预期的1.5794亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRTC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.irhythmtech.com;investors.irhythmtech.com","stockEarnings":[{"period":"1week","weight":-0.0615},{"period":"1month","weight":-0.129},{"period":"3month","weight":-0.1447},{"period":"6month","weight":-0.0928},{"period":"1year","weight":-0.39},{"period":"ytd","weight":-0.3959}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iRhythm Holdings, Inc.于2006年9月14日在美国特拉华州注册成立。iRhythm是一家领先的数字医疗公司，致力于打造值得信赖的解决方案，用于检测、预测和预防疾病。其主要业务是设计、开发和商业化基于设备的动态心脏监测技术。iRhythm相信，与依赖传统技术的其他服务相比，这些技术能够帮助临床医生更快、更高效地诊断某些心律失常。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.064957},{"month":2,"riseRate":0.7,"avgChangeRate":0.042167},{"month":3,"riseRate":0.3,"avgChangeRate":-0.034765},{"month":4,"riseRate":0.5,"avgChangeRate":-0.035735},{"month":5,"riseRate":0.4,"avgChangeRate":0.034583},{"month":6,"riseRate":0.6,"avgChangeRate":0.029927},{"month":7,"riseRate":0.4,"avgChangeRate":-0.006418},{"month":8,"riseRate":0.5,"avgChangeRate":0.09928},{"month":9,"riseRate":0.6,"avgChangeRate":0.016007},{"month":10,"riseRate":0.3,"avgChangeRate":-0.035574},{"month":11,"riseRate":0.8,"avgChangeRate":0.115712},{"month":12,"riseRate":0.4,"avgChangeRate":0.005533}],"exchange":"NASDAQ","name":"Irhythm Technologies Inc.","nameEN":"Irhythm Technologies Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Irhythm Technologies Inc.(IRTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Irhythm Technologies Inc.(IRTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Irhythm Technologies Inc.,IRTC,Irhythm Technologies Inc.股票,Irhythm Technologies Inc.股票老虎,Irhythm Technologies Inc.股票老虎国际,Irhythm Technologies Inc.行情,Irhythm Technologies Inc.股票行情,Irhythm Technologies Inc.股价,Irhythm Technologies Inc.股市,Irhythm Technologies Inc.股票价格,Irhythm Technologies Inc.股票交易,Irhythm Technologies Inc.股票购买,Irhythm Technologies Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Irhythm Technologies Inc.(IRTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Irhythm Technologies Inc.(IRTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}